Alexander Shaver Ph.D.

Rothwell, Figg, Ernst & Manbeck, P.C.

+ Follow Contact

Latest Posts › Drug Pricing

Share:

How the U.S. Compares to Europe on Biosimilar Approvals and Products In the Pipeline – Updated May 2, 2025

FDA approves Omylco® (omalizumab), first biosimilar of Xolair®. After Q1, FDA and EMA on track for a record number of biosimilar authorizations in 2025....more

5/6/2025 / Biosimilars , Drug Pricing , EU , FDA Approval , Government Agencies , Patents , Pharmaceutical Industry , Pharmaceutical Patents , Regulatory Agencies , Regulatory Requirements

1 Results

View per page

Page: of 1

Alexander Shaver Ph.D.

Rothwell, Figg, Ernst & Manbeck, P.C.

Popular Topics by This Author

Latest Posts › Drug Pricing

How the U.S. Compares to Europe on Biosimilar Approvals and Products In the Pipeline – Updated May 2, 2025

"My best business intelligence, in one easy email…"